Trojan Horse nanotheranostics with dual transformability and multifunctionality for highly effective cancer treatment

Nanotheranostics with integrated diagnostic and therapeutic functions show exciting potentials towards precision nanomedicine. However, targeted delivery of nanotheranostics is hindered by several biological barriers. Here, we report the development of a dual size/charge- transformable, Trojan-Horse nanoparticle (pPhD NP) for delivery of ultra-small, full active pharmaceutical ingredients (API) nanotheranostics with integrated dual-modal imaging and trimodal therapeutic functions. pPhD NPs exhibit ideal size and charge for drug transportation. In tumour microenvironment, pPhD NPs responsively transform to full API nanotheranostics with ultra-small size and higher surface charge, which dramatically facilitate the tumour penetration and cell internalisation. pPhD NPs enable visualisation of biodistribution by near-infrared fluorescence imaging, tumour accumulation and therapeutic effect by magnetic resonance imaging. Moreover, the synergistic photothermal-, photodynamic- and chemo-therapies achieve a 100% complete cure rate on both subcutaneous and orthotopic oral cancer models. This nanoplatform with powerful delivery efficiency and versatile theranostic functions shows enormous potentials to improve cancer treatment.Size and charge can significantly affect delivery of therapeutic agents to tumours. Here, the authors report on nanoparticles optimised for delivery to the tumour which release smaller particles and change charge in the tumour microenvironment to optimise tumour penetration and cellular uptake.

[1]  Jin-Zhi Du,et al.  Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery. , 2011, Journal of the American Chemical Society.

[2]  John Hodgson,et al.  ADMET—turning chemicals into drugs , 2001, Nature Biotechnology.

[3]  Ka Ming Ng,et al.  Cytophilic Fluorescent Bioprobes for Long‐Term Cell Tracking , 2011, Advanced materials.

[4]  Xing Guo,et al.  Size Changeable Nanocarriers with Nuclear Targeting for Effectively Overcoming Multidrug Resistance in Cancer Therapy , 2015, Advanced materials.

[5]  Gang Zheng,et al.  In situ conversion of porphyrin microbubbles to nanoparticles for multimodality imaging. , 2015, Nature nanotechnology.

[6]  Nicholas A Peppas,et al.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.

[7]  Xu Zhang,et al.  Spatiotemporal Drug Release Visualized through a Drug Delivery System with Tunable Aggregation‐Induced Emission , 2014, Advanced materials.

[8]  Wei Huang,et al.  Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug-drug conjugate for cancer therapy. , 2014, Journal of the American Chemical Society.

[9]  Jonathan F. Lovell,et al.  Ablation of Hypoxic Tumors with Dose-Equivalent Photothermal, but Not Photodynamic, Therapy Using a Nanostructured Porphyrin Assembly , 2013, ACS nano.

[10]  Jin-Zhi Du,et al.  A tumor-acidity-activated charge-conversional nanogel as an intelligent vehicle for promoted tumoral-cell uptake and drug delivery. , 2010, Angewandte Chemie.

[11]  S. Gunasekaran,et al.  Selected properties of pH‐sensitive, biodegradable chitosan–poly(vinyl alcohol) hydrogel , 2004 .

[12]  Liang Cheng,et al.  Functional nanomaterials for phototherapies of cancer. , 2014, Chemical reviews.

[13]  Kazuo Maruyama,et al.  Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.

[14]  Xing-jie Liang,et al.  Probe-inspired nano-prodrug with dual-color fluorogenic property reveals spatiotemporal drug release in living cells. , 2015, ACS nano.

[15]  Xinyuan Zhu,et al.  Synergistic Combination Chemotherapy of Camptothecin and Floxuridine through Self-Assembly of Amphiphilic Drug-Drug Conjugate. , 2015, Bioconjugate chemistry.

[16]  M. Prabaharan,et al.  Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery. , 2009, Biomaterials.

[17]  Dan Zhong,et al.  Virus‐Inspired Mimics Based on Dendritic Lipopeptides for Efficient Tumor‐Specific Infection and Systemic Drug Delivery , 2015 .

[18]  R. Müller,et al.  The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. , 1995, Advanced drug delivery reviews.

[19]  A. Ribas,et al.  Combination cancer immunotherapies tailored to the tumour microenvironment , 2016, Nature Reviews Clinical Oncology.

[20]  Xiaoyuan Chen,et al.  Rethinking cancer nanotheranostics. , 2017, Nature reviews. Materials.

[21]  D. Yan,et al.  Amphiphilic drug-drug conjugate for cancer therapy with combination of chemotherapeutic and antiangiogenesis drugs , 2020, Science China Chemistry.

[22]  Tuo Wei,et al.  Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo. , 2012, ACS nano.

[23]  Liangzhu Feng,et al.  Near-infrared light activation of quenched liposomal Ce6 for synergistic cancer phototherapy with effective skin protection. , 2017, Biomaterials.

[24]  D. Yan,et al.  Real-time self-tracking of an anticancer small molecule nanodrug based on colorful fluorescence variations , 2016 .

[25]  Chulhong Kim,et al.  Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. , 2011, Nature materials.

[26]  J Szebeni,et al.  Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. , 2003, Progress in lipid research.

[27]  Xiaoyuan Chen,et al.  Nanotheranostics for personalized medicine , 2013, Expert review of molecular diagnostics.

[28]  H. Maeda.  The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. , 2001, Advances in enzyme regulation.

[29]  Forrest M Kievit,et al.  Cancer Nanotheranostics: Improving Imaging and Therapy by Targeted Delivery Across Biological Barriers , 2011, Advanced materials.

[30]  H. Dai,et al.  PEG branched polymer for functionalization of nanomaterials with ultralong blood circulation. , 2009, Journal of the American Chemical Society.

[31]  Ting-Chao Chou,et al.  Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies , 2006, Pharmacological Reviews.

[32]  Yongfeng Zhou,et al.  Dissipative particle dynamics simulation study on the mechanisms of self-assembly of large multimolecular micelles from amphiphilic dendritic multiarm copolymers , 2013 .

[33]  Simon R. Cherry,et al.  A Smart and Versatile Theranostic Nanomedicine Platform based on Nanoporphyrin , 2014, Nature Communications.

[34]  T. Chou.  Drug combination studies and their synergy quantification using the Chou-Talalay method. , 2010, Cancer research.

[35]  Yifan Ma,et al.  Single-step assembly of DOX/ICG loaded lipid--polymer nanoparticles for highly effective chemo-photothermal combination therapy. , 2013, ACS nano.

[36]  J. Sessler,et al.  Molecular Recognition Under Interfacial Conditions: Calix[4]pyrrole-Based Cross-linkable Micelles for Ion Pair Extraction. , 2017, Journal of the American Chemical Society.

[37]  Jin-Woo Park,et al.  Supramolecular gels with high strength by tuning of calix[4]arene-derived networks , 2015, Nature Communications.

[38]  Xiangdong Xue,et al.  Self-indicating, fully active pharmaceutical ingredients nanoparticles (FAPIN) for multimodal imaging guided trimodality cancer therapy. , 2018, Biomaterials.

[39]  Ben Zhong Tang,et al.  Aggregation-induced emission. , 2011, Chemical Society reviews.

[40]  Jie Chen,et al.  Ultrasensitive pH Triggered Charge/Size Dual-Rebound Gene Delivery System. , 2016, Nano letters.

[41]  Qiang Zhang,et al.  Reduction Responsive Self-Assembled Nanoparticles Based on Disulfide-Linked Drug-Drug Conjugate with High Drug Loading and Antitumor Efficacy. , 2016, Molecular pharmaceutics.

[42]  D. Yan,et al.  Synthesis and size-controllable self-assembly of a novel amphiphilic hyperbranched multiarm copolyether , 2005 .

[43]  Jun Wang,et al.  Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy , 2016, Proceedings of the National Academy of Sciences.

[44]  Jianjun Cheng,et al.  Sequentially Responsive Shell‐Stacked Nanoparticles for Deep Penetration into Solid Tumors , 2017, Advanced materials.

[45]  Dick W. Slaaf,et al.  The endothelial glycocalyx: composition, functions, and visualization , 2007, Pflügers Archiv - European Journal of Physiology.

[46]  Song Shen,et al.  Tumor Acidity-Sensitive Polymeric Vector for Active Targeted siRNA Delivery. , 2015, Journal of the American Chemical Society.

[47]  Gang Zheng,et al.  Porphyrin-lipid stabilized gold nanoparticles for surface enhanced Raman scattering based imaging. , 2012, Bioconjugate chemistry.